source
- STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeuticsAlnylam announced a three-year deal with Inceptive, worth up to $2 billion, with $30 million up front in cash and equity in the startup.STAT · 1mo ago↗ source
- STAT+: HaloMD faces lawsuit alleging No Surprises Act middleman used ‘sham letter,’ misleading dataHighmark Health is the fourth insurer to sue HaloMD, seeking to overturn arbitration wins.STAT · 1mo ago↗ source
- Bristol Myers turns focus to AI costs after broad rollout to workersPALO ALTO, CA — After giving artificial intelligence tools to thousands of employees, Bristol Myers Squibb is now working to get a handle on the costs of the technology and where it’s actually crea…Endpoints